MedPath

Effect of real-time continuous glucose monitoring system in overweight or obese adults with prediabetes

Not Applicable
Recruiting
Conditions
Endocrine, nutritional and metabolic disease
Registration Number
KCT0004304
Lead Sponsor
Pusan National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1. = BMI 23 kg/m2
2. impaired fasting glucose (fasting glucose 100 to 125?mg/dL) or impaired glucose tolerance (2-h plasma glucose during oral glucose tolerance test (OGTT) 140 - 199 mg/dl) or HbA1c 5.7% to 6.4%

Exclusion Criteria

1. type 1 diabetes or type 2 diabetes or undergoing treatment for diabetes
2. clinical history including malignancy
3. fast history of cardiovascular disease (e.g. myocardial infarction, stroke), surgery, and trauma which may affect blood glucose within last 6 months
4. taking medication (e.g. glucocorticoid, antipsychotics, anticholinergic drug etc.) which affect blood glucose
5. acute infection within last 1 month
6. pregnancy

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1C change;weight(Kg) change
Secondary Outcome Measures
NameTimeMethod
lipid profile (total cholesterol, triglyceride, LDL-cholesterol and HDL-cholesterol) change
© Copyright 2025. All Rights Reserved by MedPath